Latest On STAAR Surgical Company (STAA):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-27 06:58 EST | News | I See Opportunity In STAAR Surgical | N/A |  |
| 2023-05-24 07:55 EST | News | STAAR Surgical: Revising To Hold Until Starting Valuations Improve (Rating Downgrade) | N/A | |
| 2023-05-04 04:22 EST | News | STAAR Surgical GAAP EPS of $0.05 beats by $0.06, revenue of $73.5M beats by $7.28M | N/A | |
| 2023-05-04 04:22 EST | News | STAAR Surgical Company (STAA) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-03 03:00 EST | News | STAAR Surgical Q1 2023 Earnings Preview | N/A | |
About STAAR Surgical Company (STAA):
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone intraocular lenses, as well as preloaded injectors for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. STAAR Surgical Company markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors. read more... The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, and Italy. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
General
- Name STAAR Surgical Company
- Symbol STAA
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Instruments & Supplies
- Full Time Employees 575
- Last Split Factor1:2
- Last Split Date1992-05-18
- Fiscal Year EndJanuary
- IPO Date1983-07-15
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.staar.com
Valuation
- Trailing PE 763.83
- Forward PE 285.71
- Price/Sales (Trailing 12 Mt.) 27.56
- Price/Book (Most Recent Quarter) 22.18
- Enterprise Value Revenue 25.89
- Enterprise Value EBITDA 429.05
Financials
- Most Recent Quarter 2021-01-31
- Profit Margin 4%
- Operating Margin 5%
- Return on Assets 2%
- Return on Equity 3%
- Revenue 163.46 million
- Earnings Per Share $0.12
- Revenue Per Share $3.58
- Gross Profit 119.56 million
- Quarterly Earnings Growth 18.3%
Highlights
- Market Capitalization 4.27 billion
- EBITDA 10.99 million
- PE Ratio 97.97
- PEG Ratio -4.89
- Analyst Target Price $119
- Book Value Per Share $4.25
Share Statistics
- Shares Outstanding 46.56 million
- Shares Float 33.85 million
- % Held by Insiders 117%
- % Held by Institutions 89.92%
- Shares Short 1.83 million
- Shares Short Prior Month 2.63 million
- Short Ratio 1.5
- Short % of Float 5%
- Short % of Shares Outstanding 4%
Technicals
- Beta 0.96
- 52 Week High $128.23
- 52 Week Low $25.05
- 50 Day Moving Average 106.43
- 200 Day Moving Average 80.15
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
STAAR Surgical Company (STAA) Dividend Calendar:
STAAR Surgical Company (STAA) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
STAAR Surgical Company (STAA) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
STAAR Surgical Company (STAA) Chart:
STAAR Surgical Company (STAA) News:
Below you will find a list of latest news for STAAR Surgical Company (STAA) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
STAAR Surgical Company (STAA) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest STAA Trades:
STAAR Surgical Company (STAA) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-05 | 8-K (Current report) | |
| 2020-11-04 | 8-K (Current report) | |
| 2020-11-04 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-10-08 | 8-K (Current report) | |
| 2020-09-16 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-14 | 8-K (Current report) | |
| 2020-09-11 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-09-02 | 8-K (Current report) | |
| 2020-08-12 | SC 13D/A (General statement of acquisition of beneficial ownership) | |
| 2020-08-12 | 3 (Initial statement of beneficial ownership of securities) | |
| 2020-08-12 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-12 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-11 | 8-K (Current report) | |
| 2020-08-07 | 8-K (Current report) | |
| 2020-08-06 | S-3/A (Registration statement under Securities Act of 1933) | |
| 2020-08-05 | 8-K (Current report) | |
| 2020-08-05 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-08-04 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-04 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-08-04 | 4 (Statement of changes in beneficial ownership of securities) | |
STAAR Surgical Company (STAA) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of STAAR Surgical Company (STAA). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 117%
Institutional Ownership: 8992%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Sell | 36,326.00 | 53.33 | 1,937,265.58 | 19,332.00 | |
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 13,217.00 | 16.15 | 213,454.55 | 32,549.00 | |
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 10,112.00 | 29.80 | 301,337.60 | 42,661.00 | |
| 2020-09-15 | Keith Holliday | Chief Technology Officer | Buy | 12,997.00 | 35.98 | 467,632.06 | 55,658.00 | |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 9,115.00 | 53.49 | 487,561.35 | 19,332.00 | |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Sell | 26,574.00 | 53.26 | 1,415,331.24 | 28,447.00 | |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 1,286.00 | 7.52 | 9,670.72 | 29,733.00 | |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 21,294.00 | 9.30 | 198,034.20 | 51,027.00 | |
| 2020-09-14 | Keith Holliday | Chief Technology Officer | Buy | 3,994.00 | 16.15 | 64,503.10 | 55,021.00 | |
| 2020-09-09 | John C Moore | Director | Sell | 137,331.00 | 52.04 | 7,146,705.24 | 21,387.00 | |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Sell | 41,602.00 | 51.22 | 2,130,854.44 | 10,794.00 | |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 16,206.00 | 9.30 | 150,715.80 | 27,000.00 | |
| 2020-08-10 | Patrick F. Williams | Chief Financial Officer | Buy | 30,727.00 | 30,727.00 | | ||
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 5,822.00 | 7.52 | 43,781.44 | 32,822.00 | |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 11,574.00 | 8.64 | 99,999.36 | 44,396.00 | |
| 2020-08-10 | Jon K. Hayashida | VP, Global Clinical, Medical | Buy | 8,000.00 | 16.15 | 129,200.00 | 52,396.00 | |
| 2020-07-30 | LOU SILVERMAN | Director | Buy | 2,117.00 | 15,850.00 | | ||
| 2020-07-30 | John C Moore | Director | Buy | 2,117.00 | 2,117.00 | | ||
| 2020-07-30 | THOMAS G FRINZI | Director | Buy | 2,117.00 | 2,117.00 | | ||
| 2020-07-30 | Gilbert H Kliman | Director | Buy | 2,117.00 | 2,581.00 | |